BGG agrees to rename astaxanthin division to settle dispute with ArticFarma

By Hank Schultz contact

- Last updated on GMT

Haematococcus pluvialis. © iStock
Haematococcus pluvialis. © iStock

Related tags: Life

Chinese company BGG has agreed to rename its astaxanthin division under an agreement with Icelandic astaxanthin supplier ArcticFarma.

ArcticFarma’s astaxanthin product is called Algalife, and the subsidiary that produces it in Keflavik, Iceland is named Algalif. The astaxanthin is produced in a closed tube system housed in buildings under artificial light. ArcticFarma CEO Andrew Jacobsen said the company’s proprietary growth system allows it to alter the wavelengths of the light to correspond to different growth stages of the organism that produces the astaxanthin, Haematococcus pluvialis​.

BGG produces its astaxanthin in a closed tube facility in Yunnan province in southwestern China using sunlight as its light source. BGG, which produces a number of other ingredients in addition to astaxanthin, had launched a division called Algae Life Sciences to house the astaxanthin business. ArcticFarma had immediate concerns about the confusion that could potentially cause and sent BGG a notice of trademark infringement.

"BGG's launch of Algae Life Sciences immediately raised concerns about confusion in the marketplace due to the similarities with our marks, Algalife and Algae for Life,"​ said Andrew Jacobson, CEO ArcticFarma.

Related topics: Markets

Related news

Show more

Follow us

Products

View more

Webinars